Aim: The aim of the present study is to prepare and evaluate nanoparticles containing Simvastatin using chitosan as the polymer. Methods: The Simvastatin loaded nanoparticles were prepared by ionic gelation of chitosan with tripolyphosphate anions. Nanoparticles of different core: coat ratio were formulated and evaluated for process yield, loading efficiency, particle size, zeta potential, in vitro drug release, kinetic studies and stability studies. Results: The prepared nanoparticles were white, free flowing and spherical in shape. The infrared spectra showed stable character of Simvastatin in the drug-loaded nanoparticles and revealed the absence of drug polymer interactions. The chitosan nanoparticles have a particle diameter ranging approximately 132.1±5.60 to 774.8±2.60nm and a zeta potential 11.93 to 43.23mV. The formulation with the initial Simvastatin concentration of 0.5 mg/ml provided the highest loading capacity. The in vitro release behavior from all the drug loaded batches were found to follow zero order and provided sustained release over a period of 10 h. No appreciable difference was observed in the extent of degradation of product during 90 days in which nanoparticles were stored at various temperatures. Conclusion: The best-fit release kinetics was achieved with zero order mechanism. The release of Simvastatin was influenced by the drug to polymer ratio and particle size. These results indicate that Simvastatin nanoparticles could be effective in sustaining drug release for a prolonged period.
Cite this article:
Suvarna G. Bhokare, Rajendra P. Marathe. Development and Bioavailability Assessment of Simvastatin Nanoparticle Formulation. Research J. Pharm. and Tech 2021; 14(3):1615-1621. doi: 10.5958/0974-360X.2021.00287.0
1. Corsini A., Maggi F.M. Catapano A.L.; Pharmacol. Res.1995, 31:9-27.
2. Patil M.S., et.al., Prepartion and optimization of simvastatin nanoparticle for solubility enhancement and in-vivo. Int. J. of Pharma Res.and Devel. 2001; 2(12): 219-226.
3. Venkateswara R. Navaneetha K., Formulation and evaluation of sustain release tablets of Ramipril. Pharmatutor. 2014; 2(7):110-9.
4. Motwani S.et.al., Chitosan–sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: Formulation, optimization and in vitro characterization. Eur.J. Pharm. Biopharma. 2008; 68(3): 513-25.
5. Ranjit K.Abdul B., Nanoparticles: An overview preparation, characterization and applications. Inter. Res J.Pharm. 2013; 4(4): 48-57.
6. Saleem V.Azharuddin S.K. Ali S, Patil C., Studies on different chitosan polyelectrolyte complex hydrogels for modified release of Diltiazem Hydrochloride. Inter. J. Pharmacy Pharma Sci. 2010; 2(4): 64-7.
7. Chouksey R.et. al. Development and bioavailability studies of Atorvastatin nanoemulsion. Int. J.Pharm Life Sci. 2011; 2(8): 982-8.
8. Ping L., Chitosan–Alginate Nanoparticles as a novel drug delivery system for Nifedipine. Inter. J. Biomedical Sci. 2008; 4(3): 221-8.
9. Tarane G, Mohm. R. et al. Evaluation of Alginate/Chitosan nanoparticles as antisense delivery vector: Formulation, optimization and in vitro characterization. Carbohydrate Polymers. 2009; 77(3): 599-606.
10. Naser M., Azam B., Ali E.Preparation of chitosan nanoparticles containing Naja Oxiana snake venom. Nanomedicine: Nanotech, Biology and Medicine. 2010; 6(1): 137-43.
11. Sangeetha S., Formulation and in vitro evaluation of sodium alginate nanospheres containing Ofloxacin. Inter. J. Applied Pharm.Sci. 2010; 2(4): 1-3.
12. Nagarwal R.C. Chitosan coated sodium alginate– chitosan nanoparticles loaded with 5-FU for ocular delivery: In vitro characterization and in vivo study in rabbit eye. Euro.J. Pharma. Sci. 2012; 47(4): 678-85.
13. Calvo P., Remuñan-López C., Vila-Jato J.L., Alonso M.J., Pharmaceutical Research, 1997, 1431-1436.
14. Shiraishi S., Imai T., Otagiri M., Controlled release of Indomethacin by chitosan-polyelectrolyte complex: optimization and in vivo/in vitro evaluation; J. Control. Release.1993; 25: 217-225
15. Purwantiningsih Sugita, L. Ambarsari, Lidiniyah, optimization of ketoprofen-chitosan loaded nanopticle by ultrasonication process; Procedia Chemistry, 2015; 16: 673-680.
16. Ananthu C Mohan, Renjanadevi B., Preparation of Zinc Oxide Nanoparticles and its Characterization Using Scanning Electron Microscopy (SEM) and X-Ray Diffraction (XRD); Procedia Tech. 2016; 24: 761–766.
17. Akhlesh K. Jain and Suresh Thareja, Invitro and in vivo characterization of pharmaceutical nanocarriers used for drug deliver; Artificial Cells. Nanomedicine and Biotechnology. 2019; 47(1): 524-539.
18. Shiraishi S., Imai T., Otagiri M.: Controlled release of Indomethacin by chitosan-polyelectrolyte complex: optimization and in vivo/in vitro evaluation. J. Control. Release, 1993; 25: 217-225.
19. R.A. Graves, G.A. Ledet, Elena Y.et al., Formulation and Evaluation of Biodegradable Nanoparticles for the Oral Delivery of Fenretinide; Eur J Pharm Sci., 2015; 30(76): 1–9.
20. Patel R., et al., Ganciclovir Loaded Chitosan Nanoparticles: Preparation and Characterization. J Nanomed Nanote. 2016, 7: 411.
21. Dandagi P., et al., Taste masked Quinine sulphate loaded solid lipid nanoparticles for flexible paediatric dosing. I. J. Pharm. Edu. Res. 2014; 48: 93-9.
22. WHO, Guidelines for stability testing of pharmaceutical products containing well established drug substances in conventional dosage forms, WHO Technical Report Series, No. 863, 1996.
23. Kaur S. et al., Preparation and Characterization of Rivastigmine Loaded Chitosan Nanoparticles. J. Pharm. Sci. Res. 2011; 3(5): 1227-32.
24. Jain S. et al., Calcium silicate-based microspheres of repaglinide for gastroretentive floating drug delivery. Preparation and in vitro characterization. J. Control. Release. 2005; 107(2): 300-9.
25. Sanyog J, et al., The effect of the oral administration of polymeric nanoparticles on the efficacy and toxicity of tamoxifen. Biomaterials. 2011; 32(2): 503-15.
26. Prajapati M.D. et al., Design, development and evaluation of nanoparticles of poorly soluble Valsartan. W. J. Pharmacy Pharm. Sci. 2013; 2(6): 5737-49.